A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Share this content:

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Sponsors and Collaborators
Seoul National University Hospital
Pfizer

Contact
Se-Hoon Lee, MD, PhD
82220722199
shlee119@snu.ac.kr

Principal Investigator
Se-Hoon Lee, MD, PhD, Seoul National University Hospital

ClinicalTrials.gov Identifier
NCT01798446

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters